Literature DB >> 22229579

The plasticity of the 7TMR signaling machinery and the search for pharmacological selectivity.

Christodoulos S Flordellis1.   

Abstract

Components of 7TMR signaling machinery once considered as rigid, fixed and inflexible entities, operating in a one-dimensional way, homogeneous spatially and temporally, are now proved to be structurally plastic, flexible and dynamic in space and time. 7TMRs are thought to exist as ensembles of multiple, inter-convertible, pre-existing conformations and this conformational diversity provides a structural plasticity and the molecular mechanism for the functional diversity of 7TMRs. Furthermore, 7TMRs appear to function not as monomers, but rather as higher order structures, within which allosteric mechanisms affect ligand binding, G protein selection and receptor mobility and signalling of GPCR protomers. Moreover, their function is regulated through compartmentalization of G protein receptor and effector molecules into specialized membrane microdomains, such as lipid rafts and caveolae. Different permutations of receptor localization and translocation in membrane microdomains and internalization patterns, employed by 7TMRs regulate their signalling. Finally, the previous clear distinction between cell signalling and endocytic membrane trafficking has been blurred by evidence that these processes are intertwined and bidirectionally linked. 7TMRs normally signaling from the plasma membrane can elicit signaling cascades from an intracellular location, with distinct biochemical outputs. All these developments have moved the search for selective drugs beyond the mere design of receptor subtype-selective ligands targeting their orthosteric site. Even the notion of ligand has been expanded, so as to include "superagonists" ", acting as "super" 7TMR agonists to confer sustained endosomal signaling and biased agonists targeting GPCRs signalling from intracellular sites, as well as pharmacochaperones restoring insufficiently folded or misfolded receptors. The plasticity of the 7TMR signaling machinery and its dynamics in space and time will most probably impact further on the search for 7TMR drug selectivity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22229579     DOI: 10.2174/138161212799040556

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  5 in total

1.  17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion.

Authors:  Yan Zhang; Dwight A Williams; Saheem A Zaidi; Yunyun Yuan; Amanda Braithwaite; Edward J Bilsky; William L Dewey; Hamid I Akbarali; John M Streicher; Dana E Selley
Journal:  ACS Chem Neurosci       Date:  2016-01-08       Impact factor: 4.418

2.  Regulation of Cell Surface CB2 Receptor during Human B Cell Activation and Differentiation.

Authors:  Julie T Castaneda; Airi Harui; Michael D Roth
Journal:  J Neuroimmune Pharmacol       Date:  2017-03-31       Impact factor: 4.147

3.  Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model.

Authors:  Clinton E Canal; Raymond G Booth; Drake Morgan
Journal:  Neuropharmacology       Date:  2013-01-23       Impact factor: 5.250

4.  A Multiplexed Fluorescent Calcium and NFAT Reporter Gene Assay to Identify GPCR Agonists.

Authors:  Heeral Sheth; Colleen Gorey; Nicole Roush; Shelly Smallman; Elizabeth Collantes; Maxine Santoro; Barbara Olson; Laura Fitzgerald; Paul H Lee; Xiqiang John Shen
Journal:  Curr Chem Genom Transl Med       Date:  2013-04-03

5.  The Antitumor Peptide ERα17p Exerts Anti-Hyperalgesic and Anti-Inflammatory Actions Through GPER in Mice.

Authors:  Christophe Mallet; Ludivine Boudieu; Sylvain Lamoine; Catherine Coudert; Yves Jacquot; Alain Eschalier
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-17       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.